Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Kalydeco
Kalydeco
Vertex Gets Uneasy On Mixed Clinical Trial Results
Seeking Alpha
Fri, 10/12/12 - 12:22 pm
Vertex Pharmaceuticals
Kalydeco
cystic fibrosis
Five Cystic Fibrosis Questions for Vertex Pharma
TheStreet.com
Tue, 10/9/12 - 04:16 pm
cystic fibrosis
Vertex Pharma
Kalydeco
VX-809
Cataract risk for kids on Vertex's cystic fibrosis pill -FDA
Reuters
Wed, 08/29/12 - 12:15 pm
cataracts
FDA
cystic fibrosis
Vertex
Kalydeco
Vertex's Cystic Fibrosis Pipeline Offers Sales Upside
Seeking Alpha
Thu, 08/2/12 - 10:22 am
cystic fibrosis
Vertex Pharma
AstraZeneca
Gilead
Kalydeco
Pfizer
Rigel Pharmaceuticals
VX-809
Vertex Pharma receives European OK for Kalydeco
Yahoo/AP
Fri, 07/27/12 - 12:07 pm
Europe
Kalydeco
Vertex Pharma
cystic fibrosis
Slice and Dice Data and Investors Will Slice You
Motley Fool
Sat, 06/30/12 - 03:31 pm
Vertex Pharmaceuticals
VX-809
Kalydeco
cystic fibrosis
Clearing Up Vertex's Data Bungle
Forbes
Fri, 06/1/12 - 12:18 pm
Vertex Pharmaceuticals
cystic fibrosis
Kalydeco
VX-809
Vertex falls after analyst expresses doubt about cystic fibrosis drug
The Fly on the Wall
Thu, 05/24/12 - 12:51 pm
Vertex Pharmaceuticals
cystic fibrosis
Kalydeco
VX-809
Vertex's Cystic Fibrosis Drug Impresses Investors
Seeking Alpha
Sun, 05/13/12 - 01:15 pm
Vertex
cystic fibrosis
VX-809
Kalydeco
Vertex shares soar on cystic fibrosis study
Markewatch
Mon, 05/7/12 - 12:12 pm
VX-809
Kalydeco
cystic fibrosis
Vertex Pharmaceuticals
Vertex Hopes Two Cystic Fibrosis Drugs Better than One
TheStreet.com
Tue, 04/24/12 - 10:36 am
cystic fibrosis
Vertex
Gilead
Bristol-Myers Squibb
Indenix
Kalydeco
VX-809
Recent FDA Approval Makes Vertex A Ripe Target For Takeover
Seeking Alpha
Thu, 03/1/12 - 12:45 pm
FDA
Vertex
M&A
Kalydeco
cystic fibrosis
FDA OKs Vertex Drug For Cystic Fibrosis; $294K/Yr
Pharmalot
Tue, 01/31/12 - 03:07 pm
FDA
cystic fibrosis
Vertex Pharmaceuticals
Kalydeco
FDA Grants Priority Review for KALYDECO™ (ivacaftor), the First Potential Medicine to Target the Underlying Cause of Cystic Fibrosis
Yahoo
Thu, 12/15/11 - 11:02 am
FDA
Kalydeco
Vertex
VX-770
cystic fibrosis
22 Hot Drugs Facing FDA Approval in 2012
TheStreet.com
Tue, 11/29/11 - 09:09 am
Amarin
AMR101
Ironwood
linaclotide
Merck
Ariad
ridaforolimus
Vivus
Qnexa
Avanafil
Amgen
Xgeva
Cell Therapeutics
pixantrone
Kalydeco
Vertex
ONYX Pharmaceuticals
Carfilzomib
Pfizer
Bristol-Myers Squibb
Eliquis
Chelsea Therapeutics
Northera
Levadex
MAP Pharmaceuticals
Roche
Curis
vismodegib
Biogen Idec
Elan
Tysabri
Amylin
Bydureon
Dapagliflozin
Uplypso
Protalix BioTherapeutics
Teva Pharmaceuticals
BioSante
Bio-T-Gel
Corlux
Corcept Therapeutics
Discovery Labs
Surfaxin
5 One-Drug Wonders Going for No. 2
Motley Fool
Tue, 11/1/11 - 11:09 am
Dendreon
Provenge
DN24-02
Elan
Tysabri
bapineuzumab
ONYX Pharmaceuticals
Bayer
regorafenib
Carfilzomib
Nexavar
Vertex
Merck
Incivek
Kalydeco
Momenta
Lovenox
Copaxone
Teva Pharmaceuticals
Vertex Seeks FDA Green Light for Cystic Fibrosis Drug, Second Potential Hit of Big Year
Xconomy
Wed, 10/19/11 - 10:39 am
Vertex
FDA
cystic fibrosis
ivacaftor
Kalydeco
VX-770
Pages
« first
‹ previous
1
2
3
4
5